Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1476-1485
doi: 10.1161/CIRCULATIONAHA.107.713339
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v119,pe550)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wallis, D. E.
Right arrow Articles by Sizemore, G. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wallis, D. E.
Right arrow Articles by Sizemore, G. W.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Nutrition
Right arrow Biochemistry and metabolism
Right arrow Other heart failure
Right arrow Primary prevention
Right arrow Risk Factors
Right arrow Hypertrophy
Right arrow Other Treatment
Right arrow Epidemiology
Right arrow Other Vascular biology

(Circulation. 2008;118:1476-1485.)
© 2008 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

The "Sunshine Deficit" and Cardiovascular Disease

Diane E. Wallis, MD; Sue Penckofer, RN, PhD; Glen W. Sizemore, MD

From Midwest Heart Specialists, Downers Grove, Ill (D.E.W.); School of Nursing, Loyola University Chicago, Maywood, Ill (S.P.); and Department of Medicine, Division of Endocrinology and Metabolism, Loyola University of Chicago Stritch School of Medicine, Maywood, Ill (G.W.S.).

Correspondence to Diane E. Wallis, MD, FACC, Midwest Heart Specialists, 3825 Highland Ave, Downers Grove, IL 60515. E-mail dwallis@midwestheart.com


Key Words: calcium • heart diseases • hyperparathyroidism • nutrition • vitamin D deficiency


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
In past decades, the primary focus on vitamin D was the recognition and treatment of deficiency as it related to metabolic bone disease (rickets, osteomalacia, and secondary hyperparathyroidism). In the last 10 years, however, with the discovery of vitamin D receptors in multiple tissue types has come the recognition that the role of vitamin D extends beyond the musculoskeletal system.1 The presence of abundant vitamin D receptors in myocardial tissue and vasculature and the observation that hypertension may be ameliorated with vitamin D suggest a greater role for vitamin D in the cardiovascular system.2 Presently, large numbers of people are found to have hypovitaminosis D (a term chosen for this review to indicate any concentration below normal under substrate-saturated conditions) resulting in part from more indoor activities and the purposeful avoidance of sunshine. This review first describes why vitamin D, parathyroid hormone (PTH), and the skeleton are important to the heart and vasculature, then outlines why the epidemic of hypovitaminosis D deserves further scrutiny by the cardiovascular community, and finally suggests why treatment options for reducing hypovitaminosis D may favorably affect the morbidity and mortality of common cardiovascular disorders.


*    Vitamin D and PTH: Basic Biochemistry and Physiology
 
Vitamin D is both a nutrient and a hormone. It is an essential precursor of calcitriol, 1,25-hydroxyvitamin D3 [1,25(OH)2D], which is necessary for bone development, growth, and mineralization and the maintenance of skeletal integrity. A cascade of steps is needed to cause progression of lesser active nutritionally ingested or synthesized vitamin D to more biologically active forms as depicted in . . . [Full Text of this Article]